Pediatrics/Neonatology, University of Florida, Gainesville, Florida, USA,
Neonatology. 2020;117(2):240-244. doi: 10.1159/000506866. Epub 2020 Mar 10.
Progress in our understanding of the pathophysiology, prevention and treatment of necrotizing enterocolitis (NEC) has been hampered for many reasons. Included among these is the fact that what we are calling "NEC" is likely to represent different disease processes, which need to be delineated before evaluating individual pathogenic mechanisms and attempting to develop predictive and diagnostic biomarkers. Treatment is also likely to be hampered because not all of the different entities called "NEC" will respond to the same regimen. In this review, some of these entities will be discussed in more detail, with suggestions for refining our approach toward improving methods for their diagnosis, prevention and treatment.
由于多种原因,我们对坏死性小肠结肠炎(NEC)的病理生理学、预防和治疗的理解进展一直受到阻碍。其中包括这样一个事实,即我们所谓的“NEC”可能代表不同的疾病过程,在评估单个发病机制并试图开发预测和诊断生物标志物之前,需要对其进行区分。治疗也可能受到阻碍,因为并非所有被称为“NEC”的不同实体都会对相同的方案产生反应。在这篇综述中,将更详细地讨论其中的一些实体,并提出改进这些实体的诊断、预防和治疗方法的建议。